ClinicalTrials.gg
Not yet recruitingNCT04804800PROSANORUpdated Jan 6, 2022

Virtual Reality Place in the Management of Body Dysmorphia Disorders in Anorexia Nervosa

An interventional study of Experimental group 1 : Virtual Reality and Experimental group 2 : Virtual Reality + Multi Sensorial Remediation in Anorexia Nervosa and Dysmorphophobia, sponsored by Lille Catholic University. Not yet recruiting. Open to female participants aged 15 Years to 26 Years. Per ClinicalTrials.gov, last updated 2022-01-06.

Sponsored by Lille Catholic University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
15 Years to 26 Years
Sex
Female
01

Study summary

Body distortions are responsible for anorexic behavior reinforcing loops. It is necessary to target this behavior and develop appropriate therapies taking into account the perceptual (implicit) and conceptual (explicit) phenomenon of body representations.

The main originality of the proposed program consists on combining virtual visual impulses and multisensory recalibration (touch, proprioception, vestibular sensations) in order to compare the body distortions evolution in anorexic patients with or without a multimodal care program including Virtual Reality from its own body scan, coupled or not to a multisensory remediation.

Read the detailed description

Rapid weight loss associated with mental anorexia leads to dysmorphophobia and body distortions. Patients perceive themselves to be bigger than they really are. Body distortions are responsible for anorexic behavior reinforcing loops. It is then necessary to target this behavior and develop appropriate therapies taking into account the perceptual (implicit) and conceptual (explicit) phenomenon of body representations.

The current treatment programs which are recommended by the Haute Autorité de Santé (HAS) in France focus on the somatic, nutritional, individual and family psychological aspects. These recommendations hardly mention the bodily distortion phenomenon which frequently leads patients to relapse into the disease.

The 3D body scanner enables to get awareness of the body through visual feedback allowing the patient to get a reassuring overview of her weight development.

This projects aims to combine virtual visual impulses and multisensory recalibration (touch, proprioception, vestibular sensations) in order to compare the body distortions evolution in anorexic patients with or without a multimodal care program including Virtual Reality from its own body scan coupled or not to a multisensory remediation.

02

Conditions studied

  • Anorexia Nervosa
  • Dysmorphophobia

Keywords

  • Anorexia Nervosa
  • Dysmorphophobia
  • Body distortions
  • Multisensory remediation
  • Virtual Reality
03

In context

Anorexia Nervosa

469 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.

This study's planned enrollment of 150 is above the median of 46 across 313 interventional studies indexed under Anorexia Nervosa.

Browse Anorexia Nervosa studies →

Lead sponsor

Lille Catholic University is the lead sponsor of 112 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 26 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female
  • Age ≥ 15 to ≤ 26 years old
  • Anorexic nervosa eating disorder according to the criteria of , Fifth Edition (DSM 5). As patients are hospitalized for anorexic nervosa, the medical diagnosis of each care center participating in the inclusions will be trusted
  • Patient hospitalized (full hospitalization or day hospital) in one of the investigative centers for a minimum period of 6 weeks
  • 14 ≤ ≤ 18.5 for adult patients. For minors, Cole's curves will be used. The Body mass index (BM)I should be between the 1st percentile and the 10th percentile (if the weight curve shows a clear break indicating abnormal weight loss). For example, for a 15-year-old girl, the BMI should be between 14.5 and 16.8.
  • Presence of body distortion (BSC ≥ 20%)
  • French language mastery
  • Affiliation to a social security system
  • Signature of to participate in this study by the patient and by her parents in the case of underage patients

Exclusion criteria

Exclusion Criteria:

  • Associated major mental disorders (psychotic disorders, bipolar disorders, major depression)
  • Neurological disorders (pyramidal or extrapyramidal syndromes)
  • Substance addiction (drugs, alcohol)
  • Any disorder likely to impair the reasoning, discernment or judgment abilities
  • Psychological incapacity to answer the questionnaires
  • Medical to the practice of physical activity (identical contraindication to people without anorexia. In fact, appropriate physical activity is prescribed in anorexic patients in order to reduce the cardiovascular risks, osteopenia or anxiety and allow them to become aware of an adapted physical practice (reduction of anarchic physical hyperactivity)
  • Participation in other research programs or psychomotor treatments in parallel
  • Pregnant or breastfeeding woman
  • Persons under guardianship, curatorship or legal protection
  • Blindness, eye infections, mask wounds, poorly balanced epilepsy, psychiatric disorders incompatible with virtual reality
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • No intervention
    Control group

    The patients benefit from the care recommended by the HAS. They benefit from psychological interviews, psychiatric follow-up, dietetic follow-up, family interviews and therapy. Body therapies (physiotherapy, massage, fascia therapy, psychomotor skills, dance therapy, etc.) may also take place. Patients will also benefit from relaxation and body scan.

  • Experimental
    Experimental group 1 : Virtual Reality

    The patients benefit from the care recommended by the HAS, the virtual reality program and time for relaxation and body scan (1 hour).

    Other: Experimental group 1 : Virtual Reality

  • Experimental
    Experimental group 2 : Virtual Reality + Multi Sensorial Remediation

    The patients benefit from the care recommended by the HAS, the virtual reality and the multisensory remediation programs, and also the body scan.

    Other: Experimental group 2 : Virtual Reality + Multi Sensorial Remediation

Interventions

  • OtherExperimental group 1 : Virtual Reality

    Patients benefit from the care recommended by the HAS, the virtual reality program and time for relaxation and body scan.

  • OtherExperimental group 2 : Virtual Reality + Multi Sensorial Remediation

    Patients benefit from the care recommended by the HAS, the virtual reality program, the multisensory remediation, and also the body scan.

06

What researchers measure

Primary outcomes

  1. Change in Body Dimensions Estimation task

    Body overestimation bias will be assessed by the Body Dimensions Estimation task.

    Time frame: 6 weeks

Secondary outcomes

  1. Change in Body Shape Questionnaire

    The womens body image concerns will be evaluated by the Body Shape Questionnaire. This 34-items questionnaire is scored from 1 (= never) to 6 (= always) to obtain a global score.

    Time frame: 6 weeks

  2. Change in Physical self description questionnaire

    The Physical self description will be measured by the Physical Self Description Questionnaire (PSQD). This questionnaire estimates 11 sub-dimensions of the physical self from 70 items on a continuum ranging from 1 (very negative perception) to 6 (very positive perception).

    Time frame: 6 weeks

  3. Change in Body Image Questionnaire

    Patients bodily satisfaction will be assessed by the Body Image Questionnaire. This questionnaire consists of 19 items scored on 5 points. It gives a total body satisfaction score between 19 and 95 and 4 scores relative to 4 different factors (accessibility/closure, satisfaction/dissatisfaction, active/passive, serenity/tension).

    Time frame: 6 weeks

  4. Change in Weight gain

    Weight gain will be measured by weighting.

    Time frame: 6 weeks

  5. Change in Eating Disorder Examination Questionnaire

    Eating disorders will be assessed by the Eating Disorder Examination Questionnaire (EDE-Q). This questionnaire is divided into several sub-scores: restriction, dietary concerns, body shape concerns and weight concerns. It has 30 items scored from 0 (= no day) to 6 (= every day). A score for each subscale and an overall score can be obtained.

    Time frame: 6 weeks

  6. Anxiety measured by the State-Trait Anxiety Inventory (STAI-Etat-Trait)

    Anxiety will be measured by the STAI-Etat-Trait . Each of the dimensions (STAI-state and Stai-trait) are measured by 20 items scored from 1 (= no or never) to 4 (= yes or almost always) which is summarized by a score.

    Time frame: 6 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2022; primary completion for May 2025, 32 months later.

Of 151 non-industry interventional studies with no phase under Anorexia Nervosa, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 63. This study's planned 32 months is below that.

Counting every sponsor, half of 151 studies reached it within 43 months; a quarter within 24 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 16, 2021
First posted
Mar 18, 2021
StartEst.
Sep 2022
Primary completionEst.
May 2025
CompletionEst.
May 2026
Last update
Jan 6, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04804800
Responsible party
Sponsor
First posted
Mar 18, 2021
Start date
Sep 2022 (estimated)
Primary completion
May 2025 (estimated)
Completion
May 2026 (estimated)
Last update
Jan 6, 2022

Study contacts

Amélie Lansiaux, PhD, MD
Contact
lansiaux.amelie@ghicl.net
03.20.22.52.69
Anne-Sophie Blain, CRA
Contact
blain.anne-sophie@ghicl.net
03.20.22.57.32
Vincent Dodin, PhD
principal investigator · Hôpital Saint-Vincent de Paul

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion